0001181431-12-047604.txt : 20120827 0001181431-12-047604.hdr.sgml : 20120827 20120827212932 ACCESSION NUMBER: 0001181431-12-047604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120823 FILED AS OF DATE: 20120827 DATE AS OF CHANGE: 20120827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christopher Nishan Garabedian CENTRAL INDEX KEY: 0001492604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 121058236 MAIL ADDRESS: STREET 1: 333 RIVER STREET STREET 2: #303 CITY: HOBOKEN STATE: NJ ZIP: 07030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-354-5038 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 rrd354490.xml X0306 4 2012-08-23 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001492604 Christopher Nishan Garabedian 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL WA 98021 1 1 0 0 President and CEO Stock Option (Right to Buy) 10.08 2012-08-23 4 A 0 150000 0 A 2022-08-23 Common Stock 150000 150000 D Stock Appreciation Right 10.08 2012-08-23 4 A 0 70000 0 A 2022-08-23 Common Stock 70000 70000 D 25% of the shares subject to the option will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the stock appreciation right (SAR) will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. /s/ Christopher Nishan Garabedian 2012-08-27